These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 18035071)

  • 21. Automatic remote monitoring utilizing daily transmissions: transmission reliability and implantable cardioverter defibrillator battery longevity in the TRUST trial.
    Varma N; Love CJ; Schweikert R; Moll P; Michalski J; Epstein AE;
    Europace; 2018 Apr; 20(4):622-628. PubMed ID: 29016878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost savings and safety of ICD remote control by telephone: a prospective, observational study.
    Bikou O; Licka M; Kathoefer S; Katus HA; Bauer A
    J Telemed Telecare; 2010; 16(7):403-8. PubMed ID: 20870684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of 57,148 transmissions by remote monitoring of implantable cardioverter defibrillators.
    Theuns DA; Rivero-Ayerza M; Knops P; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S63-5. PubMed ID: 19250114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remote detection of incessant slow VT with an ICD capable of home monitoring.
    Siaplaouras S; Buob A; Neuberger HR; Mewis C
    Europace; 2006 Jul; 8(7):512-4. PubMed ID: 16760231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What are the professional and logistic demands to appropriately follow patients with an implantable cardioverter-defibrillator?
    Schaer BA; Sticherling C; Osswald S
    J Intern Med; 2006 Jul; 260(1):88-92. PubMed ID: 16789983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
    Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
    Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and economic impact of remote monitoring on the follow-up of patients with implantable electronic cardiovascular devices: an observational study.
    Costa PD; Reis AH; Rodrigues PP
    Telemed J E Health; 2013 Feb; 19(2):71-80. PubMed ID: 23336734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation.
    Ricci RP; Morichelli L; Santini M
    Europace; 2009 Jan; 11(1):54-61. PubMed ID: 19011260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-hospital follow-up of implantable cardioverter defibrillator and pacemaker carriers: patients' inconvenience and points of view. A four-hospital Italian survey.
    Gramegna L; Tomasi C; Gasparini G; Scaboro G; Zanon F; Boaretto G; Tomei R; Tomasi L
    Europace; 2012 Mar; 14(3):345-50. PubMed ID: 22080472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remote monitoring of patients with implantable cardioverter-defibrillators: can results from large clinical trials be transposed to clinical practice?
    Morichau-Beauchant T; Boulé S; Guédon-Moreau L; Finat L; Botcherby EJ; Périer MC; Salleron J; Guibout C; Marquié C; Klug D; Kouakam C; Wissocque L; Brigadeau F; Lacroix D; Kacet S
    Arch Cardiovasc Dis; 2014 Dec; 107(12):664-71. PubMed ID: 25241223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The benefits of a remote monitoring system in longterm follow up of patients with implantable cardioverter  defibrillators].
    Ošmera O; Bulava A
    Vnitr Lek; 2013 Apr; 59(4):269-76. PubMed ID: 23711052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator.
    Quesada A; Almendral J; Arribas F; Ricci R; Wolpert C; Adragao P; Cobo E; Navarro X;
    Europace; 2004 Mar; 6(2):142-50. PubMed ID: 15018874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The place of telemedicine in rhythmology and cardiac pacing].
    Lamaison D; Motreff P; Jean F; Geoffroy E; Rodriguez R; Souteyrand G; Chanseaume S; Terrazoni S; Cassagnes J
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1160-4. PubMed ID: 15609921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of a remote monitoring system for implantable cardioverter defibrillators.
    Masella C; Zanaboni P; Di Stasi F; Gilardi S; Ponzi P; Valsecchi S
    J Telemed Telecare; 2008; 14(6):290-4. PubMed ID: 18776073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Remote management of pacemakers and implantable cardioverter defibrillators: an application of telemedicine].
    Ganière V; Burri H
    Rev Med Suisse; 2011 Mar; 7(285):548-50, 552-3. PubMed ID: 21488395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of atrial fibrillation by implanted devices with wireless data transmission capability.
    Varma N; Stambler B; Chun S
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S133-6. PubMed ID: 15683480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators.
    Berger RD; Lerew DR; Smith JM; Pulling C; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):749-53. PubMed ID: 16836672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial.
    Hindricks G; Elsner C; Piorkowski C; Taborsky M; Geller JC; Schumacher B; Bytesnik J; Kottkamp H
    Eur Heart J; 2014 Jan; 35(2):98-105. PubMed ID: 23868932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
    Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
    Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.